AcelRx Pharmaceuticals Inc. Daily Stock Analysis

Daily Stock Analysis, ACRX, AcelRx Pharmaceuticals Inc, priceseries

AcelRx Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
0.40
Close
0.38
High
0.42
Low
0.38
Previous Close
0.40
Daily Price Gain
-0.02
YTD High
0.65
YTD High Date
Jan 4, 2022
YTD Low
0.33
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.23
YTD Gain
-36.90%
52 Week High
2.30
52 Week High Date
Mar 12, 2021
52 Week Low
0.33
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-1.39
52 Week Gain
-78.25%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jul 14. 2017
2.40
Aug 1. 2017
3.21
12 Trading Days
33.75%
Link
LONG
Mar 8. 2018
1.90
Mar 19. 2018
2.01
7 Trading Days
5.90%
Link
LONG
May 10. 2018
2.50
Jun 25. 2018
3.87
31 Trading Days
54.84%
Link
LONG
Sep 13. 2018
3.40
Sep 28. 2018
3.92
11 Trading Days
15.19%
Link
LONG
Jan 2. 2019
2.48
Jan 11. 2019
2.64
7 Trading Days
6.50%
Link
LONG
Feb 14. 2019
2.63
Mar 5. 2019
3.15
12 Trading Days
19.80%
Link
LONG
Apr 23. 2019
3.51
May 1. 2019
3.72
6 Trading Days
5.91%
Link
LONG
Jul 5. 2019
2.45
Jul 19. 2019
2.74
10 Trading Days
11.69%
Link
LONG
Sep 3. 2019
2.30
Sep 19. 2019
2.53
12 Trading Days
9.97%
Link
LONG
Dec 6. 2019
1.87
Dec 30. 2019
2.17
15 Trading Days
16.28%
Link
LONG
Mar 24. 2020
0.95
Apr 1. 2020
1.07
6 Trading Days
12.17%
Link
LONG
Aug 6. 2020
1.17
Aug 18. 2020
1.25
8 Trading Days
6.58%
Link
LONG
Sep 16. 2020
1.28
Sep 24. 2020
1.41
6 Trading Days
10.35%
Link
LONG
Oct 7. 2020
1.44
Oct 15. 2020
1.71
6 Trading Days
18.95%
Link
LONG
Jan 11. 2021
1.36
Feb 1. 2021
2.15
14 Trading Days
58.01%
Link
LONG
Mar 9. 2021
1.96
Mar 10. 2021
2.10
1 Trading Days
7.14%
Link
LONG
May 26. 2021
1.35
Jun 15. 2021
1.46
13 Trading Days
7.89%
Link
Company Information
Stock Symbol
ACRX
Exchange
NasdaqGM
Company URL
http://www.acelrx.com
Company Phone
650-216-3500
CEO
Vincent J. Angotti
Headquarters
California
Business Address
351 GALVESTON DRIVE, REDWOOD CITY, CA 94063
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001427925
About

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. Its product candidates is comprised of DSUVIA, and ZALVISO, which both contains sufentanil as a therapeutic ingredient. The company was founded by Thomas A. Schreck and Pamela P. Palmer on July 13, 2005 and is headquartered in Redwood City, CA.

Description

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet, which is in Phase III clinical trial for the treatment of moderate-to-severe acute pain. The company's late-stage investigational product candidate is Zalviso, a pre-programmed and patient-controlled analgesia device that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. Zalviso is approved in the European Union, Switzerland, Liechtenstein, Iceland, Norway and Australia, or the Territory; and is under development stage in the United States. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading